NEW YORK--(BUSINESS WIRE)--Cynvec LLC, a privately-held biopharmaceutical company focused on developing novel cancer therapies that harness the apoptotic ability of the Sindbis viral vector, today announced that executive management will participate in the NYSSA 12th Annual Biotech and Specialty Pharma Conference in New York on December 2, 2008. The conference is being held at 1177 Avenue of the Americas, 2nd floor, New York City. Frank D. Stonebanks, President and Chief Executive Officer, is scheduled to present an overview of the company at 1:00 p.m. ET today.
